Skip to main content
OpenTrials

Clinical trial condition

Influenza Immunization

Explore clinical trials studying Influenza Immunization. Study availability and eligibility vary by location and protocol.

19 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Influenza Immunization trial results

Completed

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

NCT06695130

Conditions
COVID-19 Immunization, Infections, Influenza Immunization, +6 more
Locations
  • Central Phoenix Medical Clinic- Site Number : 8400009 Phoenix, Arizona, United States
  • Synexus Clinical Research US, Inc. - Cerritos- Site Number : 8400002 Cerritos, California, United States
  • Synexus Clinical Research US - Vista- Site Number : 8400010 Vista, California, United States
  • Optimal Research - Florida- Site Number : 8400006 Melbourne, Florida, United States
View Trial Details
Completed

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

NCT06695117

Conditions
COVID-19 Immunization, Infections, Influenza Immunization, +6 more
Locations
  • Simon Williamson Clinic - Birmingham- Site Number : 8400003 Birmingham, Alabama, United States
  • AES - DRS - Optimal Research Alabama - Huntsville Site Number : 8400006 Huntsville, Alabama, United States
  • Orange Grove Family Practice- Site Number : 8400012 Tucson, Arizona, United States
  • Synexus Clinical Research US - The Villages- Site Number : 8400011 The Villages, Florida, United States
View Trial Details
Completed

Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older

NCT06727058

Conditions
Infections, Influenza Immunization, Influenza, Human, +5 more
Locations
  • Velocity Clinical Research - San Diego- Site Number : 8400013 La Mesa, California, United States
  • Accel Research Sites Network - DeLand Clinical Research Unit- Site Number : 8400002 DeLand, Florida, United States
  • ARSN-Lakeland CRU- Site Number : 8400006 Lakeland, Florida, United States
  • Accel Research Sites - St. Petersburg- Site Number : 8400004 Largo, Florida, United States
View all 14 locations
View Trial Details
Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older

NCT04498832

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number 3920005 Fukuoka, Japan
  • Investigational Site Number 3920004 Koganeishi, Japan
  • Investigational Site Number 3920006 Kumamoto, Japan
  • Investigational Site Number 3920001 Osaka, Japan
View Trial Details
Completed

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

NCT05426174

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • AES - DRS - Optimal Research_Site 8400007 Huntsville, Alabama, United States
  • Central Phoenix Medical Clinic, LLC_Site: 8400010 Phoenix, Arizona, United States
  • Optimal Research San Diego, LLC_Site: 8400009 San Diego, California, United States
  • AES - DRS - Optimal Research_Site 8400002 Melbourne, Florida, United States
View Trial Details
Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

NCT04024228

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number 0560001 Ghent, Belgium
  • Investigational Site Number 0560002 Wilrijk, Belgium
  • Investigational Site Number 2500001 Gières, France
  • Investigational Site Number 2500004 Paris, France
View all 17 locations
View Trial Details
Completed

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

NCT04969276

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number :8400003 Glendale, Arizona, United States
  • Investigational Site Number :8400006 San Diego, California, United States
  • Investigational Site Number :8400004 Vista, California, United States
  • Investigational Site Number :8400005 Centennial, Colorado, United States
View Trial Details

Related conditions